Adoption of Memorandum of Association (MOA) and Articles of Association (AOA) as per Companies Act, 2013.

Negative operating cash flowResults View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.1%Reaction day

₹81.50

prior close

₹80.81

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-7.2% vs market

Pharmaceuticals peers, median of 160sector+0.2%-6.3% vs sector

On the reaction day the stock moved 7.2 pts less than Nifty Microcap 250 and 6.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.5

10m

-3.5

15m

-4.3

30m

-4.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.1+1.1-7.2+0.2-6.3

Next day

-6.2+1.2-7.4+0.2-6.4

-6.3+2.8-9.1+1.5-7.8

-6.1+3.5-9.7+1.4-7.6

-6.1+3.5-9.6+1.6-7.7

-6.1+2.8-9.0+1.0-7.2

-7.5+2.8-10.3+0.4-7.9

15d

-2.5+4.2-6.7+0.7-3.2

-3.2+10.1-13.3+3.1-6.3

-1.4+10.0-11.4+7.2-8.6

-6.3+14.6-20.8+8.2-14.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma reported FY2026 revenue of Rs 77,166 lakhs, up 16.6% from Rs 66,151 lakhs in FY2025. However, profit after tax declined 13.3% to Rs 4,105 lakhs from Rs 4,735 lakhs. EBITDA margin compressed to 8.56% from 10.64% year-on-year. Operating cash flow turned negative at Rs 301 lakhs (vs positive Rs 3,712 lakhs in FY2025) due to inventory buildup of Rs 7,327 lakhs and higher trade receivables. The board declared dividend of Rs 1.50/share (30% payout), appointed new internal auditors RMJ & Associates LLP, and recommended re-election of two directors. Promoter group shareholders holding 0.95% (9.5 lakh shares) sought re-classification to public category. Auditors issued an unmodified opinion. Bonus shares (1:1) were issued in July 2025.

Likely market impact

Revenue growth is below 20%, while PAT declined and margins compressed significantly. Negative operating cash flow despite positive net profit is a concern, suggesting working capital pressure. Clean audit and dividend provide some support. The inventory surge and receivables growth warrant monitoring.

By the numbersStandalone · Q4 FY26 vs Q4 FY25

	Q4 FY26	Q4 FY25	Change
Revenue	₹202.1 Cr	₹198.1 Cr	+2.0%
Operating profit	₹16.77 Cr	₹15.88 Cr	+5.6%
Profit after tax	₹11.68 Cr	₹12.46 Cr	−6.2%
EBITDA margin	9.8%	9.4%	+0.4 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.